4baseCare

Executive Summary

4baseCare is an Indian precision oncology company leveraging genomic diversity and AI to personalize cancer care. Founded in 2020 and headquartered in Bangalore, the company has developed platforms such as OncoTwin and the Global Cancer Diversity Atlas, which integrate multi-modal genomic data from tissue, liquid biopsy, and germline samples with AI-powered analytics. This approach enables comprehensive genomic testing and clinical decision support for cancer patients, addressing the underrepresentation of diverse populations in genomic databases. With a commercial-stage presence and a team of 50-200 employees, 4baseCare aims to improve treatment outcomes by tailoring therapies based on individual genetic profiles and population-specific variations. The company's focus on India's genetically diverse population provides a unique advantage in building a robust cancer genomics database. By combining AI with multi-modal data, 4baseCare offers actionable insights for oncologists and researchers, potentially accelerating drug development and clinical trial recruitment. As precision oncology gains traction globally, 4baseCare is positioned to capture market share in both domestic and international markets. However, competition from established players and the need for regulatory clearances pose challenges. Overall, the company's innovative technology and niche focus on genomic diversity make it a compelling player in the precision oncology space.

Upcoming Catalysts (preview)

• Q3 2026Commercial launch of OncoTwin platform for clinical decision support70% success
• Q4 2026Strategic partnership with a global pharmaceutical company for clinical trial genomics50% success
• Q2 2026Series A funding round to scale operations and expand into new markets75% success